|
Market Closed -
Other stock markets
|
After hours 19:55:22 | |||
| 19.28 USD | +2.01% |
|
19.10 | -0.96% |
| 07-24 | US FDA approves over-the-counter Tylenol combination pill for pain relief | RE |
| 07-24 | Kenvue's Tylenol With Naproxen Combination Tablet Gets FDA Approval for Pain Relief | MT |
| Market Cap | 37.02B 32.51B 30.24B 27.75B 52.13B 3,565B 52.94B 359B 140B 1,753B 139B 136B 6,060B | P/E 2026 * |
20.2x | P/E 2027 * | 18x |
|---|---|---|---|---|---|
| Enterprise Value | 44.42B 39.02B 36.29B 33.3B 62.56B 4,278B 63.53B 431B 168B 2,103B 167B 163B 7,272B | EV / Sales 2026 * |
2.84x | EV / Sales 2027 * | 2.74x |
| Free-Float |
98.9% | Yield 2026 * |
4.4% | Yield 2027 * | 4.5% |
Last Transcript: Kenvue Inc.
| 1 day | +2.01% | ||
| 1 week | +1.58% | ||
| Current month | +0.89% | ||
| 1 month | +2.55% | ||
| 3 months | +10.23% | ||
| 6 months | +8.31% | ||
| Current year | +11.77% |
| 1 week | 18.77 |  | 19.28 |
| 1 month | 18.58 | | 20.13 |
| Current year | 16.56 | | 20.13 |
| 1 year | 14.02 | | 22.74 |
| 3 years | 14.02 | | 25.23 |
| 5 years | 14.02 | | 27.8 |
| 10 years | 14.02 | | 27.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kirk Perry
CEO | Chief Executive Officer | 56 | 2025-07-13 |
Heather Howlett
DFI | Director of Finance/CFO | 48 | 2026-05-11 |
| Chief Tech/Sci/R&D Officer | 57 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Larry Merlo
CHM | Chairman | 70 | 2023-04-30 |
Vasant M. Prabhu
BRD | Director/Board Member | 66 | 2023-05-03 |
Richard Allison
BRD | Director/Board Member | 59 | 2023-05-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/29/26 | Starboard Value LP
| Other | Company | 1,413 | 0.0001% | |
| 6/29/26 | Free | Director | 1,413 | 0.0001% | ||
| 6/10/26 | Sell | Chief Financial Officer | -3,700 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.01% | +1.58% | -14.31% | -20.20% | 37.02B | |
| +1.05% | -1.71% | -7.18% | -3.92% | 343B | |
| +0.72% | -2.09% | -9.54% | +1.21% | 131B | |
| +0.74% | -2.40% | +2.60% | +17.13% | 72.62B | |
| -0.78% | +0.06% | -12.01% | -16.87% | 52.33B | |
| +0.46% | -2.24% | -7.47% | -54.65% | 29.05B | |
| -0.26% | -2.34% | -30.49% | -32.52% | 19.29B | |
| -0.03% | -2.57% | -5.88% | +22.97% | 17.81B | |
| +0.09% | -1.16% | -13.47% | +2.23% | 11.26B | |
| +0.01% | -0.94% | -17.43% | -25.14% | 7.8B | |
| Average | +0.27% | -1.38% | -11.52% | -10.98% | 72.19B | |
| Weighted average by Cap. | +0.15% | -1.59% | -8.15% | -4.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.63B 13.72B 12.76B 11.71B 22.01B 1,505B 22.34B 152B 59.21B 740B 58.66B 57.39B 2,558B | 16.02B 14.07B 13.09B 12.01B 22.56B 1,543B 22.91B 155B 60.71B 759B 60.14B 58.85B 2,623B |
| Net income | 1.84B 1.62B 1.51B 1.38B 2.6B 177B 2.64B 17.87B 6.98B 87.25B 6.92B 6.77B 302B | 2.06B 1.81B 1.69B 1.55B 2.91B 199B 2.95B 20.03B 7.82B 97.76B 7.75B 7.58B 338B |
| Net Debt | 7.41B 6.5B 6.05B 5.55B 10.43B 713B 10.59B 71.84B 28.07B 351B 27.8B 27.2B 1,212B | 6.81B 5.98B 5.56B 5.1B 9.59B 656B 9.74B 66.06B 25.81B 322B 25.57B 25.02B 1,115B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | US$19.28 | +2.01% | 21,434,276 |
| 26-07-23 | US$18.90 | -1.20% | 14,410,892 |
| 26-07-22 | US$19.13 | +0.63% | 9,899,890 |
| 26-07-21 | US$19.01 | -0.05% | 12,703,960 |
| 26-07-20 | US$19.02 | +0.21% | 12,222,234 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KVUE Stock
Select your edition
All financial news and data tailored to specific country editions
